*By Christian Smith*
After an overdose earlier this week, Demi Lovato's life was reportedly saved by Narcan, a nasal administrator of naloxone that counteracts the effects of opioids. When administered quicklyーthrough either nasal mist or injectionーnaloxone can temporarily halt an overdose, allowing EMTs enough time to respond. The medication is available without a prescription in 49 states, and the generic version costs about $20 per dose.
But all merits aside, is the drug's accessibility enabling addicts to push their limits?
Dr. Roger Crystal, the lead inventor of Narcan and CEO of Opiant Pharmaceuticals, says there's little evidence to support that concern.
"Addiction like any kind of chronic disease is something you can control using better medication, but ultimately you can't cure," Crystal told Cheddar. "To think about an opioid addict behaving rationally and saying, 'well because I have access to Narcan I'll shoot more heroin, inject more heroin' there's no proof for that whatsoever."
Naloxone is considered some of the best ammunition on the front lines of America's growing opioid epidemic. A reported 2 million Americans have an addition to opioidsーand the number isn't going down. U.S. Surgeon General Jerome Adams [issued an advisory](https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html) in April urging anyoneーand their close family and friendsーwho uses painkillers, heroin, fentanyl, or other opioids to carry naloxone in case of an emergency.
Crystal isn't stopping at Narcan: he told Cheddar he's also developing a heroin vaccine, suggesting the inventor has lofty ambitions for the future of overdose prevention.
Although Crystal may be aware of lingering ethical concerns, he doesn't think they dwarf his mission. After all, Lovato has him to thank.
"Putting it in the hands of everyone and anyone is critical," Crystal said.
For more on this story, [click here](https://cheddar.com/videos/how-one-pharmaceutical-company-is-fighting-the-opioid-epidemic).
If someone told you that asthma would help you win gold at the Olympics, would you believe them? Well according to a new study, athletes with asthma are more likely to win at the Winter Games than those without these breathing problems. Popular Science's Claire Maldarelli explains why.
Amazon launches health products line, Chipotle adds quinoa to the menu, and Tinder reveals the most-swiped athletes in the Olympic Village.
Will Goodman, managing editor at Rockets are Cool, discusses The Boring Company securing a preliminary permit for its proposed New York to DC hyperloop.
Jason Brown, CEO of Vitamin Packs, discusses how his company can deliver improved health right to your door. Vitamin Packs is a start-up subscription service that delivers personalized vitamins to consumers once a month.
Clayton Banks, CEO of tech incubator Silicon Harlem, and Jessica O. Matthews, CEO of Uncharted Power, discuss their combined effort to make New York City's Harlem neighborhood the Silicon Valley of the East Coast.
Clayton Banks, CEO of Silicon Harlem, and Jessica Matthews, CEO of Uncharted Power, are teaching the community how to build, grow, and scale their businesses.
If you are addicted to emotional shows like "This Is Us," you are not alone. And now, there is research to show why we love to cry and watch emotional TV.
Billionaire Tom Steyer is putting his personal fortune behind an effort to get President Trump out of office. Special counsel Robert Mueller has indicted 13 Russian nationals and three Russian entities for allegedly meddling in the 2016 presidential election. Coinbase users took to social media and Reddit to complain about glitches on the platform. Coinbase says the root of the problem is credit card processing managed by Visa. But, Visa says they didn't cause the problem.
"Girls" star and director Lena Dunham is sparking a national dialogue on women's health after revealing she had a hysterectomy. LiveScience's Sara Miller and SELF's Casey Gueren join Cheddar to reveal why the star elected to have the procedure.
Snap CEO Evan Spiegel is doubling down on the app redesign. Shake Shack plans to open 32-35 new locations this year. Miso Robotics, the firm behind automated burger-flipper, "Flippy," The company behind a patty-flipping robot just got a major influx of cash.
